News
Article
Pharmaceutical Technology
Pharmaceutical Technology-04-15-2014Volume2014 eBook Issue 1
A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D
Author(s):
A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.
Previous studies with EUDRAGIT NM 30 D showed that storage stability can be achieved with in-process curing at specific conditions. The aim of this study was to identify and investigate the influence and correlation of critical process parameters for the optimization of in-process curing.
Download
Pharmaceutical Technology’s 2014 Solid Dosage and Excipients eBook.
Articles in this issue
Safety by Design—Mitigating the Risk of Medication Errors Through Product Design
Controlled-Release Technologies Create Opportunities for Solid-Dosage Drug Formulators
Continuous Manufacturing for Solid-Dosage Drug Production
A Practical Guide to Hot-Melt Extrusion Scale-Up for Pharmaceutical Applications
Using Modular Systems in Solid-Dosage Manufacturing
Advances in Hot-Melt Extrusion Manufacturing
Obtaining User-Defined Particle Size Distribution Using Dry Granulation
A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D
Selection of Excipients in Generic Formulations
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
